As the electricity consumption of AI is projected to double by 2026, neuromorphic computing emerges as a promising solution. Researchers at The University of Texas at San Antonio are advancing neuromorphic computing, a field that applies principles of neuroscience to computing systems to mimic the brain’s function and structure. Neuromorphic chips have the potential to outpace traditional computers in energy and space efficiency as well as performance, presenting substantial advantages across various domains, including artificial intelligence, health care and robotics. To achieve scale in neuromorphic computing, the team proposes several key features that must be optimized, including sparsity, a feature observed in the biological brains. 

A new study by researchers at the Department of Molecular Medicine at SDU sheds light on one of the most severe consequences of stroke: damage to the brain's "cables"—the so-called nerve fibers—which leads to permanent impairments. The study, which is based on unique tissue samples from Denmark's Brain Bank located at SDU, may pave the way for new treatments that help the brain repair itself.

A new consensus provides an update on the use of molecular diagnostics for hepatocellular carcinoma and biliary tract cancer,which both present significant health challenges. The expert panel has developed evidence-based recommendations that emphasize personalized treatment strategies and key molecular markers to optimize therapy. The consensus also explores emerging biomarkers, such as tumor mutation burden and microsatellite instability, which are crucial for advancing precision medicine and improving patient outcomes.

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the molecular mechanisms underlying its progression is crucial for developing effective therapies. A recent study has uncovered a critical role of the BOLA3 gene and its exon 3 inclusion, which is promoted by the heterogeneous nuclear ribonucleoprotein C (HNRNPC), in accelerating ESCC progression. This discovery provides new insights into the molecular pathology of ESCC and may have implications for the development of targeted therapies.